Armstrong, A., N. Agada, W. Xu, and G. Gallo. “An Update on the Long-Term Safety Experience of Ixekizumab: Results from the Psoriasis Clinical Development Program With More Than 3 Years of Follow-up from 12 Clinical Trials and More Than 15000 Patient-Years of Exposure to Ixekizumab”. SKIN The Journal of Cutaneous Medicine, vol. 2, Dec. 2018, p. S116, doi:10.25251/skin.2.supp.105.